Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Nuvolone

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Haematologica|November 12, 2013
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approachGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
NPJ Vaccines|February 13, 2024
Author Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
NPJ Vaccines|January 20, 2024
The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
The Journal of Experimental Medicine|October 23, 2013
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cellsMario Nuvolone, Veronika Kana, Gregor Hutter, et al.
International Journal of Molecular Sciences|June 2, 2021
Tau Exon 10 Inclusion by PrP<sup>C</sup> through Downregulating GSK3β ActivityLaia Lidón, Laura Llaó-Hierro, Mario Nuvolone, et al.
Brain Pathology (Zurich, Switzerland)|February 18, 2022
Glial activation in prion diseases is selectively triggered by neuronal PrP<sup>Sc</sup>Asvin K K Lakkaraju, Silvia Sorce, Assunta Senatore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Regulated expression of amyloidogenic immunoglobulin light chains in miceMario Nuvolone, Silvia Sorce, Pawel Pelczar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosisGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Annals of Hematology|May 3, 2011
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomideGiovanni Palladini, Paola Russo, Andrea Foli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 24, 2012
The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's diseaseMegan Larson, Mathew A Sherman, Fatou Amar, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Haematologica|November 12, 2013
Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approachGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
NPJ Vaccines|February 13, 2024
Author Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
NPJ Vaccines|January 20, 2024
The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
The Journal of Experimental Medicine|October 23, 2013
SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cellsMario Nuvolone, Veronika Kana, Gregor Hutter, et al.
International Journal of Molecular Sciences|June 2, 2021
Tau Exon 10 Inclusion by PrP<sup>C</sup> through Downregulating GSK3β ActivityLaia Lidón, Laura Llaó-Hierro, Mario Nuvolone, et al.
Brain Pathology (Zurich, Switzerland)|February 18, 2022
Glial activation in prion diseases is selectively triggered by neuronal PrP<sup>Sc</sup>Asvin K K Lakkaraju, Silvia Sorce, Assunta Senatore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Regulated expression of amyloidogenic immunoglobulin light chains in miceMario Nuvolone, Silvia Sorce, Pawel Pelczar, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosisGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Annals of Hematology|May 3, 2011
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomideGiovanni Palladini, Paola Russo, Andrea Foli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 24, 2012
The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's diseaseMegan Larson, Mathew A Sherman, Fatou Amar, et al.
Pageof 12